The August issue of the Journal of Clinical Endocrinology and Metabolism includes the recently developed Endocrine Society guideline on the treatment of Cushing’s Syndrome. This guideline, previewed during a presentation at the March, 2015 annual ENDO meeting, was prepared by a task force of experts following an extensive literature review process. The guideline, co-sponsored by the European Society of Endocrinology, will provide endocrinologists and other medical professionals with treatment recommendations based on evidence from the medial literature. Dr. Lynnette Nieman, NIH, NICHD, Bethesda, MD chaired the task force which also included Beverly M.K. Biller of Massachusetts General Hospital in Boston, MA; James W. Findling of the Medical College of Wisconsin in Milwaukee, WI; M. Hassan Murad of the Mayo Clinic in Rochester, MN; John Newell-Price of the University of Sheffield in Sheffield, U.K.; Martin O. Savage of the William Harvey Research Institute at Barts and the London School of Medicine and Dentistry in London, U.K.; and Antoine Tabarin of CHU de Bordeaux and INSERM at the University of Bordeaux, Bordeaux France. The CSRF believes that this guideline will assist in the transfer of knowledge from experts in Cushing’s to other endocrinologists with less experience, resulting in better patient care. You might want to let your physicians know about this important guideline. Watch for a patient level summary of the guideline in the December newsletter.